U.S. federal trademark · Serial No. 77057346
Human blood substitute, namely specialized hemoglobin-cardiovascular pharmaceutical combination to provide super-accelerated oxygen delivery with ultrafast onset, fluid-sparing and hematocrit-elevating properties; the pharmaceutical treatment is intended for both military and civilian use in field/hospital emergency, surgical or critical care medical services
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.